Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Short- and long-term outcome following laparoscopic versus open resection for carcinoma of the rectum in the multimodal setting.

Kellokumpu IH, Kairaluoma MI, Nuorva KP, Kautiainen HJ, Jantunen IT.

Dis Colon Rectum. 2012 Aug;55(8):854-63. doi: 10.1097/DCR.0b013e31825b9052.

PMID:
22810470
2.

Absence of cytomegalovirus from the gastrointestinal tract of patients with active Crohn's disease.

Aarnio MT, Böhm JP, Nuorva KP, Pitkänen RI, Kuopio TH, Voutilainen ME.

In Vivo. 2012 Jan-Feb;26(1):151-5.

PMID:
22210731
3.

Quality of surgical care, local recurrence, and survival in patients with low- and midrectal cancers following multimodal therapy.

Kellokumpu I, Vironen J, Kairaluoma M, Jantunen I, Kautiainen H, Nuorva K.

Int J Colorectal Dis. 2012 Jan;27(1):111-20. doi: 10.1007/s00384-011-1322-5. Epub 2011 Oct 26.

PMID:
22038306
4.

Remission of membranous glomerulonephritis after pancreatectomy for pancreatic neuroendocrine neoplasm - a rare coincidence.

Forslund T, Kellokumpu I, Elomaa E, Arola J, Nuorva K.

Clin Nephrol. 2011 Feb;75 Suppl 1:42-6.

PMID:
21269593
5.

High frequency of TTK mutations in microsatellite-unstable colorectal cancer and evaluation of their effect on spindle assembly checkpoint.

Niittymäki I, Gylfe A, Laine L, Laakso M, Lehtonen HJ, Kondelin J, Tolvanen J, Nousiainen K, Pouwels J, Järvinen H, Nuorva K, Mecklin JP, Mäkinen M, Ristimäki A, Ørntoft TF, Hautaniemi S, Karhu A, Kallio MJ, Aaltonen LA.

Carcinogenesis. 2011 Mar;32(3):305-11. doi: 10.1093/carcin/bgq272. Epub 2010 Dec 16.

PMID:
21163887
6.

Mutations in the circadian gene CLOCK in colorectal cancer.

Alhopuro P, Björklund M, Sammalkorpi H, Turunen M, Tuupanen S, Biström M, Niittymäki I, Lehtonen HJ, Kivioja T, Launonen V, Saharinen J, Nousiainen K, Hautaniemi S, Nuorva K, Mecklin JP, Järvinen H, Orntoft T, Arango D, Lehtonen R, Karhu A, Taipale J, Aaltonen LA.

Mol Cancer Res. 2010 Jul;8(7):952-60. doi: 10.1158/1541-7786.MCR-10-0086. Epub 2010 Jun 15.

7.

Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors.

Parkkila S, Lasota J, Fletcher JA, Ou WB, Kivelä AJ, Nuorva K, Parkkila AK, Ollikainen J, Sly WS, Waheed A, Pastorekova S, Pastorek J, Isola J, Miettinen M.

Mod Pathol. 2010 May;23(5):743-50. doi: 10.1038/modpathol.2009.189. Epub 2010 Jan 15.

8.

Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia.

Nieminen TT, Gylling A, Abdel-Rahman WM, Nuorva K, Aarnio M, Renkonen-Sinisalo L, Järvinen HJ, Mecklin JP, Bützow R, Peltomäki P.

Clin Cancer Res. 2009 Sep 15;15(18):5772-83. doi: 10.1158/1078-0432.CCR-09-0506. Epub 2009 Sep 1.

9.

Differential cancer predisposition in Lynch syndrome: insights from molecular analysis of brain and urinary tract tumors.

Gylling AH, Nieminen TT, Abdel-Rahman WM, Nuorva K, Juhola M, Joensuu EI, Järvinen HJ, Mecklin JP, Aarnio M, Peltomäki PT.

Carcinogenesis. 2008 Jul;29(7):1351-9. doi: 10.1093/carcin/bgn133. Epub 2008 Jun 12.

PMID:
18550572
10.

Allelic imbalance at rs6983267 suggests selection of the risk allele in somatic colorectal tumor evolution.

Tuupanen S, Niittymäki I, Nousiainen K, Vanharanta S, Mecklin JP, Nuorva K, Järvinen H, Hautaniemi S, Karhu A, Aaltonen LA.

Cancer Res. 2008 Jan 1;68(1):14-7. doi: 10.1158/0008-5472.CAN-07-5766.

11.

Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.

Gylling A, Abdel-Rahman WM, Juhola M, Nuorva K, Hautala E, Järvinen HJ, Mecklin JP, Aarnio M, Peltomäki P.

Gut. 2007 Jul;56(7):926-33. Epub 2007 Jan 31.

12.

Nitric oxide synthase in human salivary glands.

Soinila J, Nuorva K, Soinila S.

Histochem Cell Biol. 2006 Jun;125(6):717-23. Epub 2005 Dec 9.

PMID:
16341869
13.
14.

Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. The Central Finland Endoscopy Study Group.

Voutilainen M, Färkkilä M, Juhola M, Nuorva K, Mauranen K, Mäntynen T, Kunnamo I, Mecklin JP, Sipponen P.

Am J Gastroenterol. 1999 Apr;94(4):913-8.

PMID:
10201456
15.
16.

Pulmonary adiaspiromycosis in a two year old girl.

Nuorva K, Pitkänen R, Issakainen J, Huttunen NP, Juhola M.

J Clin Pathol. 1997 Jan;50(1):82-5.

17.

Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma.

Soini Y, Nuorva K, Kamel D, Pöllänen R, Vähäkangas K, Lehto VP, Pääkkö P.

Thorax. 1996 Sep;51(9):887-93.

18.

p53 protein accumulation and the presence of human papillomavirus DNA in bronchiolo-alveolar carcinoma correlate with poor prognosis.

Nuorva K, Soini Y, Kamel D, Pöllänen R, Bloigu R, Vähäkangas K, Pääkkö P.

Int J Cancer. 1995 Dec 20;64(6):424-9.

PMID:
8550245
19.

p53 protein accumulation in lung carcinomas of patients exposed to asbestos and tobacco smoke.

Nuorva K, Mäkitaro R, Huhti E, Kamel D, Vähäkangas K, Bloigu R, Soini Y, Pääkkö P.

Am J Respir Crit Care Med. 1994 Aug;150(2):528-33.

PMID:
8049841
20.

p53 and c-erbB-2 expression in schistosomal urinary bladder carcinomas and schistosomal cystitis with premalignant lesions.

Kamel D, Soini Y, Nuorva K, Khalifa A, Mangoud A, Vähäkangas K, Pääkkö P.

Virchows Arch. 1994;424(4):349-55.

PMID:
7911381
21.

p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression.

Soini Y, Turpeenniemi-Hujanen T, Kamel D, Autio-Harmainen H, Risteli J, Risteli L, Nuorva K, Pääkkö P, Vähäkangas K.

Br J Cancer. 1993 Nov;68(5):1029-35.

22.

Tenascin immunoreactivity in lung tumors.

Soini Y, Pääkkö P, Nuorva K, Kamel D, Linnala A, Virtanen I, Lehto VP.

Am J Clin Pathol. 1993 Aug;100(2):145-50.

PMID:
7689293
23.

p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder.

Kamel D, Pääkkö P, Nuorva K, Vähäkangas K, Soini Y.

J Pathol. 1993 May;170(1):67-72.

PMID:
8100854
24.

Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas.

Nuorva K, Soini Y, Kamel D, Autio-Harmainen H, Risteli L, Risteli J, Vähäkangas K, Pääkkö P.

Am J Pathol. 1993 Mar;142(3):725-32.

25.
26.

p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours.

Soini Y, Vähäkangas K, Nuorva K, Kamel D, Lane DP, Pääkkö P.

J Pathol. 1992 Sep;168(1):29-33.

PMID:
1333524
27.

Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas.

Soini Y, Pääkkö P, Nuorva K, Kamel D, Lane DP, Vähäkangas K.

Virchows Arch A Pathol Anat Histopathol. 1992;421(3):223-8.

PMID:
1413488
28.

Low p53 protein expression in salivary gland tumours compared with lung carcinomas.

Soini Y, Kamel D, Nuorva K, Lane DP, Vähäkangas K, Pääkkö P.

Virchows Arch A Pathol Anat Histopathol. 1992;421(5):415-20.

PMID:
1333678
29.

[Chlorpropamide and the alcohol flush reaction and coronary artery disease in adult diabetics].

Nuorva K, Laakso M, Aro A, Uusitupa M, Siitonen O, Huupponen R.

Duodecim. 1984;100(5):278-83. Finnish. No abstract available.

PMID:
6714113
30.

Chlorpropamide-alcohol flushing and coronary heart disease in non-insulin dependent diabetics.

Laakso M, Nuorva K, Aro A, Uusitupa M, Siitonen O, Huupponen R.

Br Med J (Clin Res Ed). 1983 Apr 23;286(6374):1317-8. No abstract available.

Supplemental Content

Loading ...
Support Center